|
EIF2B2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.319790E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.231800E-01 |
| Normal-vs-Stage2 |
3.182900E-03 |
| Normal-vs-Stage3 |
5.266200E-02 |
| Normal-vs-Stage4 |
7.835400E-01 |
| Stage1-vs-Stage2 |
2.680300E-02 |
| Stage1-vs-Stage3 |
1.708240E-01 |
| Stage1-vs-Stage4 |
5.060000E-01 |
| Stage2-vs-Stage3 |
4.656000E-01 |
| Stage2-vs-Stage4 |
8.522200E-02 |
| Stage3-vs-Stage4 |
2.029400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.112400E-01 |
| Normal-vs-AfricanAmerican |
9.275700E-03 |
| Normal-vs-Asian |
5.750600E-01 |
| Caucasian-vs-AfricanAmerican |
6.525500E-02 |
| Caucasian-vs-Asian |
5.707400E-01 |
| AfricanAmerican-vs-Asian |
1.221160E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.174200E-01 |
| Normal-vs-Female |
1.375030E-01 |
| Male-vs-Female |
7.507600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.757940E-03 |
| Normal-vs-Age(41-60Yrs) |
4.556400E-01 |
| Normal-vs-Age(61-80Yrs) |
2.254600E-01 |
| Normal-vs-Age(81-100Yrs) |
8.267700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.039760E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.215800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.949400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.176600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.130800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.589000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.430200E-01 |
| Normal-vs-Grade 2 |
4.285000E-01 |
| Normal-vs-Grade 3 |
1.295790E-01 |
| Normal-vs-Grade 4 |
2.797800E-01 |
| Grade 1-vs-Grade 2 |
8.351900E-02 |
| Grade 1-vs-Grade 3 |
3.160500E-02 |
| Grade 1-vs-Grade 4 |
7.873800E-02 |
| Grade 2-vs-Grade 3 |
3.514000E-01 |
| Grade 2-vs-Grade 4 |
4.533400E-01 |
| Grade 3-vs-Grade 4 |
7.901200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.948200E-01 |
| Normal-vs-ccB subtype |
3.744500E-03 |
| ccA subtype-vs-ccB subtype |
1.940490E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.834400E-01 |
| Normal-vs-N1 |
9.004000E-03 |
| N0-vs-N1 |
5.959900E-02 |
|
|
